首页 | 本学科首页   官方微博 | 高级检索  
     


Drug repurposing for hyperlipidemia associated disorders: An integrative network biology and machine learning approach
Affiliation:1. Dep. of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt;2. Faculty of Pharmacy, New Mansoura University, New Mansoura, Egypt;1. Neusentis, Pfizer Research & Development, Cambridge, CB21 6GS, UK;2. Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, CB2 0RE, UK;3. Cellectricon, MoIndal, 431 37, Sweden;4. BenevolentAI Cambridge Ltd, Cambridge, CB22 3AT, UK;5. Pfizer World Wide Research & Development, Cambridge, MA 02139, USA;6. Mission Therapeutics, Cambridge, CB22 3AT, UK
Abstract:
Keywords:Repurposing  Drug-target network  Hyperlipidemia  Driver nodes  Machine learning
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号